# Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

> **NCT00363584** · PHASE3 · COMPLETED · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 360 (estimated)

## Conditions studied

- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Liver Cancer

## Interventions

- **DRUG:** capecitabine
- **OTHER:** clinical observation
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00363584
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00363584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00363584, "Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00363584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*